News
USA News Group News Commentary – Artificial intelligence is rapidly transforming the healthcare sector, with adoption of AI ...
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...
Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years ...
The stock is up 8.6% since reporting and currently trades at $510.02. Is now the time to buy Vertex Pharmaceuticals? Access our full analysis of the earnings results here, it’s free. Pioneering ...
The expanded collaboration now allows Reddit to use Google’s Vertex AI, which enables users to build, deploy, and scale machine learning models and AI applications, the author notes. Easily ...
In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.
Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results